275 related articles for article (PubMed ID: 2699997)
1. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
[TBL] [Abstract][Full Text] [Related]
2. Correlation between intradialytic hypotension in patients undergoing routine hemodialysis and use of acetate compared in bicarbonate dialysate.
Thaha M; Yogiantoro M; Soewanto ; Pranawa
Acta Med Indones; 2005; 37(3):145-8. PubMed ID: 16138418
[TBL] [Abstract][Full Text] [Related]
3. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients.
Elisaf M; Bairaktari E; Katopodis K; Pappas M; Sferopoulos G; Tzallas C; Tsolas O; Siamopoulos KC
Am J Nephrol; 1998; 18(5):416-21. PubMed ID: 9730566
[TBL] [Abstract][Full Text] [Related]
4. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
Böhles H; Michalk D; von Wendt-Göknur E
Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
[TBL] [Abstract][Full Text] [Related]
5. [The effect of acetate and bicarbonate hemodialysis on protein and lipid metabolism in patients with chronic kidney failure].
Shostka GD; T'iagi S; Rumiantsev ASh; Kozlov VV; Smirnov AV; Kulikova AI
Ter Arkh; 1990; 62(6):88-92. PubMed ID: 2218936
[TBL] [Abstract][Full Text] [Related]
6. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
7. Lipoperoxidation and hemodialysis.
Ramos R; Martínez-Castelao A
Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
[TBL] [Abstract][Full Text] [Related]
8. [Bicarbonate hemodialysis in the therapy of chronic kidney failure].
Riabov SI; Shostka GD; Spiridonov VN; Vasil'ev AN; Kozlov VV
Ter Arkh; 1988; 60(5):76-80. PubMed ID: 3175934
[TBL] [Abstract][Full Text] [Related]
9. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and analytical changes in hemodialysis without acetate].
Coll E; Pérez-García R; Rodríguez-Benítez P; Ortega M; Martínez Miguel P; Jofré R; López-Gómez JM
Nefrologia; 2007; 27(6):742-8. PubMed ID: 18336105
[TBL] [Abstract][Full Text] [Related]
12. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
[TBL] [Abstract][Full Text] [Related]
13. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.
Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M
Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175
[TBL] [Abstract][Full Text] [Related]
14. [The effect of acetate and bicarbonate on the tolerance for hemodialysis therapy in chronic kidney failure].
Shostka GD; T'iagi S; Kulikova AI; Spiridonov VN; Kostkina MI; Vitenberg AG
Urol Nefrol (Mosk); 1990; (6):39-44. PubMed ID: 2089765
[TBL] [Abstract][Full Text] [Related]
15. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
Glöggler A; Bulla M; Fürst P
Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
[TBL] [Abstract][Full Text] [Related]
16. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
[TBL] [Abstract][Full Text] [Related]
17. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F
Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
19. Effect of L-carnitine on the serum lipoproteins and HDL-C subclasses in hemodialysis patients.
Argani H; Rahbaninoubar M; Ghorbanihagjo A; Golmohammadi Z; Rashtchizadeh N
Nephron Clin Pract; 2005; 101(4):c174-9. PubMed ID: 16103722
[TBL] [Abstract][Full Text] [Related]
20. The effect of L-carnitine on lipid metabolism in patients on chronic haemodialysis.
Yderstraede KB; Pedersen FB; Dragsholt C; Trostmann A; Laier E; Larsen HF
Nephrol Dial Transplant; 1987; 1(4):238-41. PubMed ID: 3110681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
